AnalystsYale JenYale Jen's Stock Forecasts
AnalystsYale Jen
Analyst Ranking
Bottom 5%
#4678 out of 4906 analysts
Average Return
-37.77%
Win Rate
19%3 out of 16
Risk vs Reward
Poor
Good
Yale Jen's 5 best and worst ratings
Yale Jen Analyst Color
Get additional color on Yale Jen's coverage of popular stocks
Yale Jen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Senti Biosciences IncSNTI | 1 | Strong Buy | $5.00 | +92.31% | Initiates Coverage On | 10 days ago |
Soleno Therapeutics IncSLNO | 1 | Strong Buy | $105.00 | +32.66% | Maintains | 3 months ago |
Nuvectis Pharma IncNVCT | 1 | Strong Buy | $19.00 | +125.92% | Initiates Coverage On | 3 months ago |
Lifeward LtdLFWD | 1 | Strong Buy | $10.00 | +809.09% | Initiates Coverage On | 4 months ago |
Abivax SaABVX | 1 | Strong Buy | $48.00 | +587.68% | Initiates Coverage On | a year ago |
Affimed NvAFMDQ | 1 | Strong Buy | $25.00 | N/A | Maintains | a year ago |
Biomx IncPHGE | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | a year ago |
In8bio IncINAB | 1 | Strong Buy | $225.00 | N/A | Initiates Coverage On | a year ago |
Silo Pharma IncSILO | 1 | Strong Buy | $10.00 | N/A | Initiates Coverage On | 2 years ago |
Bellerophon Therapeutics IncBLPH | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Nls Pharmaceutics LtdNLSP | 1 | Strong Buy | $240.00 | N/A | Initiates Coverage On | 3 years ago |
Evofem Biosciences IncEVFM | 1 | Strong Buy | $3.50 | N/A | Initiates Coverage On | 3 years ago |
Cingulate IncCING | 1 | Strong Buy | $2,040.00 | N/A | Initiates Coverage On | 3 years ago |
Vincerx Pharma IncVINC | 1 | Strong Buy | $600.00 | N/A | Initiates Coverage On | 4 years ago |
F Star Therapeutics IncFSTX | 1 | Strong Buy | $32.00 | N/A | Initiates Coverage On | 4 years ago |
Athenex IncATNXQ | 1 | Strong Buy | $720.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.